Total number of studies N = 51 | ||||||
---|---|---|---|---|---|---|
Sensitivity | Specificity | PLR | NLR | DOR | Studies | |
Electrocardiography (ECG) | 55.1% (95% CI: 45.2–64.6) | 84.5 (95% CI: 74.6–91.0) | 2.719 (95% CI: 1.654–4.469) | 0.494 (95% CI: 0.309–0.789) | 5.975 (95% CI: 2.675–13.349) | 28 |
Troponin I | 64.4% (95% CI: 52.3–74.9) | 84.1% (95% CI: 72.3–91.5) | 3.792 (95% CI: 2.181–6.594) | 0.329 (95% CI: 0.170–0.638) | 15.009 (95% CI: 6.910–32.603) | 17 |
Troponin T | 68.4% (95% CI: 40.2–87.5) | 85.8% (95% CI: 73.6–92.9) | 4.368 (95% CI: 2.473–7.715) | 0.217 (95% CI: 0.120–0.395) | 16.048 (95% CI: 7.453—34.558) | 6 |
Creatine phosphokinase-MB (CK-MB) | 55.2% (95% CI: 43.1–66.6) | 75.8% (95% CI: 62.7–85.4) | 1.927 (95% CI: 1.370–2.711) | 0.523 (95% CI: 0.386–0.710) | 3.598 (95% CI: 1.832–7.068) | 22 |
Transthoracic Echocardiography (TTE) | 47.0% (95% CI: 34.2–60.2) | 91.4 (95% CI: 84.3–95.5) | 3.558 (95% CI: 1.967–6.436) | 0.446 (95% CI: 0.249–0.799) | 10.077 (95% CI: 3.845–26.408) | 20 |
Transoesophageal Echocardiography (TEE) (case reports included) | 93.1% (95% CI: 76.5–98.2) | 87.6% (95% CI: 46.1–98.3) | 5.711 (95% CI: 1.065–30.613) | 0.131 (95% CI: 0.034–0.513) | 59.994 (95% CI: 1.947–1848.814) | 5 |
Transoesophageal Echocardiography (TEE) (case reports excluded) | Sensitivity: 86.7% (range 40.0–99.2) | Specificity: 72.1% (range 35.8–98.2) | NA | NA | NA | 3 |
Electrocardiography (ECG) and Troponin I* | 34% | 75% | NA | NA | NA | 10 |
Electrocardiography (ECG) or Troponin I* | 87.5% | 25% | NA | NA | NA | 11 |